スピルホスタチンAの全合成は,強力なヒストン脱酸化酵素阻害剤である
Alexander Yurek-George1, Fay Habens, Matthew Brimmell
1School of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom.
Journal of the American Chemical Society
|January 30, 2004
まとめ
スピルホスタチンAの全合成が達成され,その構造が確認され,ヒストン脱エチラゼ (HDAC) 阻害剤に似た生物学的活性が明らかにされました. 立体化学はHDACの相互作用に不可欠であり,エピメリックアナログは不活性であることが判明した.
科学分野:
- 有機化学 オーガニック・ケミストリー
- 薬用化学 薬用化学について
- 分子生物学は分子生物学である.
背景:
- スピルコスタチンAは,潜在的な治療用途を持つ複雑な天然製品です.
- ヒストン脱セチラーゼ (HDAC) 阻害剤は,様々な疾患に対する臨床試験中の薬剤の重要なクラスです.
- スピルコスタチンAのような新種の化合物の構造-活性関係を理解することは,薬の開発において極めて重要です.
研究 の 目的:
- スピルホスタチンAの全合成を達成し,それによって提案された構造を明確に確認します.
- スピルホスタチンAとその類似体の生物学的活性を調べる.
- スピルホスタチンAの生物学的活動における立体化学の役割,特にHDACとの相互作用を明らかにする.
主な方法:
- ナガオチアゾリジネチオンの補助物質を用いた総合成で,ダイアステロ選択性アルドール反応とアミド形成を行う.
- ヤマグチプロトコルを使用したマクロラクトニゼーション.
- HDACの抑制を評価し,FK228.8のような既知の阻害剤との活性を比較するための生物学的測定法.
主要な成果:
- スピルコスタチンAの完全な合成が成功し,その分子構造が確認されました.
- スピルコスタチンAは,強力なヒストン脱酸化酵素阻害剤であるFK228に匹敵する生物学的活性を示しています.
- スピルホスタチンAのアナログである,β-ヒドロキシ酸位置でのエピメリックは,不活性であることが判明し,特定の立体化学の重要性を強調しました.
結論:
- 総合合成はスピルホスタチンAの構造を検証する.
- スピルコスタチンAは,HDAC阻害剤の開発のための有望な新しい支架を表しています.
- ベータ-ヒドロキシ酸のステレオ化学は,スピルコスタチンAがHDACと相互作用し,その観察された生物学的活性にとって重要です.
関連する概念動画
02:25Spreading of Chromatin Modifications
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Writers
The writer is an enzyme that can...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...